Souhaitez-vous accéder aux communiqués récents ?

LONDON, April 01, 2026 (GLOBE NEWSWIRE) -- M&A transactions of $10 billion or more have hit an all-time record in the first three months of 2026, according to research on completed deals from...

Distribution agreement to enhance channel partner expansion across five U.S. states The collaboration is expected to support adoption of advanced 3D imaging within orthopedic practices and surgical...

Greenlane Holdings Announces 1-for-8 Reverse Stock Split

ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical...

MIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) today announced financial results for the fiscal year ended December 31, 2025. The growing media and substrate...

PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...

Trevi Therapeutics to host an Investor and Analyst Day on May 7th in NYC and participate in key upcoming events.

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Software-Defined Wide Area Network (SD-WAN) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report encompasses...

Foundation for Sarcoidosis Research Launches See Sarcoidosis Campaign for April's Awareness Month

GARDian3 trial enrollment and dosing completed (N=63) in less than nine monthsTopline results expected in 2Q27 with BLA to follow by mid-2027OCU410ST represents a potential first-in-class, one-time...